Applied DNA Sciences, Inc. (APDN)

NASDAQ: APDN · IEX Real-Time Price · USD
0.708
-0.030 (-4.09%)
At close: Jul 1, 2022 4:00 PM
0.730
+0.022 (3.107%)
Pre-market: Jul 5, 2022 8:08 AM EDT

Company Description

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes.

The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims.

It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark.

In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies.

Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes.

The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002.

Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Applied DNA Sciences, Inc.
Applied DNA Sciences Logo
Country United States
Founded 1983
Industry Electronic Equipment, Instruments & Components
Sector Information Technology
Employees 78
CEO James Hayward

Contact Details

Address:
50 Health Sciences Dr
Stony Brook, New York 11790-3349
United States
Phone 631 840 8800
Website adnas.com

Stock Details

Ticker Symbol APDN
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency US Dollars
CIK Code 0000744452
CUSIP Number 03815U102
ISIN Number US03815U3005
Employer ID 59-2262718
SIC Code 2865

Key Executives

Name Position
Dr. James A. Hayward Ph.D., Sc.D. Chairman, President and Chief Executive Officer
Beth M. Jantzen CPA, CPA Chief Financial Officer
Judith Murrah Chief Operating Officer, Chief Information Officer and Secretary
Scott L. Anchin Strategic Advisor and Independent Director
Sanjay M. Hurry Executive Director of Investor Relations and Corporate Communications
Clay Shorrock Esq., J.D. Chief Legal Officer and Executive Director of Business Development
John Shearman Executive Director of Marketing and Cannabis Business
Tony Benson Managing Director of EMEA
Janice Meraglia Vice President, Gov. and Military Programs
MeiLin Wan Vice President of Textile Sales

Latest SEC Filings

Date Type Title
May 12, 2022 8-K Current report
May 12, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
Feb 23, 2022 424B5 Prospectus [Rule 424(b)(5)]
Feb 22, 2022 8-K Current report
Feb 14, 2022 SC 13D General statement of acquisition of beneficial ownership
Feb 14, 2022 SC 13G/A Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022 8-K Current report
Feb 10, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
Jan 28, 2022 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 13, 2022 SC 13G/A Statement of acquisition of beneficial ownership by individuals